Global Cephalosporin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cephalosporin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".
Cephalosporin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cephalosporin market is projected to reach US$ 1346.9 million in 2034, increasing from US$ 1380.7 million in 2022, with the CAGR of -0.3% during the period of 2024 to 2034. Demand from Oral and Injection are the major drivers for the industry.
Market competition is intense. Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACS Dobfar are the top 5 of Cephalosporin, with about 50% market shares.China is the largest supplier of Cephalosporin, with a production market share nearly 70%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 21%.China is the largest consumption place, with a consumption market share nearly 40%. Following China, India is the second largest consumption place with the consumption market share of 39%. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 61%.Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cephalosporin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Liaoning Medya Pharmaceutical.
Sichuan Kelun Pharmaceutical
Suzhou Dawnrays Pharmaceutical
Fuan Pharmaceutical
Harbin Pharmaceutical Group
Shandong Ruiying Pioneer Pharmaceutical
Guangdong Liguo Pharmaceutical
Nectar Lifesciences
ACS Dobfar
Novartis
Segment by Type
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Oral
Injection
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Cephalosporin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cephalosporin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cephalosporin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cephalosporin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cephalosporin introduction, etc. Cephalosporin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cephalosporin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".
Cephalosporin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cephalosporin market is projected to reach US$ 1346.9 million in 2034, increasing from US$ 1380.7 million in 2022, with the CAGR of -0.3% during the period of 2024 to 2034. Demand from Oral and Injection are the major drivers for the industry.
Market competition is intense. Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACS Dobfar are the top 5 of Cephalosporin, with about 50% market shares.China is the largest supplier of Cephalosporin, with a production market share nearly 70%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 21%.China is the largest consumption place, with a consumption market share nearly 40%. Following China, India is the second largest consumption place with the consumption market share of 39%. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 61%.Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cephalosporin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Liaoning Medya Pharmaceutical.
Sichuan Kelun Pharmaceutical
Suzhou Dawnrays Pharmaceutical
Fuan Pharmaceutical
Harbin Pharmaceutical Group
Shandong Ruiying Pioneer Pharmaceutical
Guangdong Liguo Pharmaceutical
Nectar Lifesciences
ACS Dobfar
Novartis
Segment by Type
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Segment by Application
Oral
Injection
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Cephalosporin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cephalosporin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cephalosporin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cephalosporin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cephalosporin introduction, etc. Cephalosporin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cephalosporin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.